At the time, Rosas could not have predicted that Sikka’s job would include combating a virus that spiraled into a global pandemic and caused the NBA to shut down. Now, Sikka and the Mayo Clinic — an academic medical center headquartered in Rochester, Minnesota — are spearheading a leaguewide study that aims to establish what percentage of NBA players, coaches, executives and staff have developed antibodies to the coronavirus.
Timberwolves, Mayo Clinic to lead leaguewide coronavirus study
![](https://feeds.usatodaysports.com/wp-content/uploads/2020/05/i_c8_f2_49_gersson-rosas-3.png)